sleep disorders Daytime sleepiness, pathological melatonin and cortisol levels
Conditions
Interventions
Group 1: Patient group exposed to the light intervention during the first week of observation.
Group 2: Patient group exposed to the light intervention in the second week of observation.
Sponsors
Universitätsklinikum RWTH Aachen
Eligibility
Sex/Gender
All
Age
70 Years to No maximum
Inclusion criteria
Inclusion criteria: Male and female patients, capacity to consent, geriatric trauma patients
Exclusion criteria
Exclusion criteria: Active COVID-19 infection, cognitive deficits measured with the Mini-Mental-Status (standard at admission to program of geriatric early rehabilitative complex therapy) at value <25
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| melatonin level, cortisol level | — |
Secondary
| Measure | Time frame |
|---|---|
| subjective sleep quality, perceived sleep duration, daytime sleepiness by means of sleep diary in the morning and in the evening, heart rate, sleep duration, movement during sleep by means of actigraphy | — |
Countries
Germany
Contacts
Public ContactSvenja Lange
Universitätsklinikum RWTH Aachen
Outcome results
None listed